NSJ Bioreagents

CA19-9 Antibody

Product Code:
 
NSJ-V7255SAF
Product Group:
 
Primary Antibodies
Supplier:
 
NSJ Bioreagents
Host Type:
 
Rabbit
Antibody Isotype:
 
Rabbit IgG kappa
Antibody Clonality:
 
Recombinant Antibody
Antibody Clone:
 
CA19.9/1390R
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Immunohistochemistry- Paraffin Embedded (IHC-P)
Storage:
 
Store the recombinant CA19-9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
1 / 2
IHC testing of FFPE human gastric carcinoma with recombinant CA19-9 antibody (clone CA19.9/1390R). HIER: steam sections in pH6 citrate buffer for 10-20 min.~
2 / 2
SDS-PAGE Analysis of Purified, BSA-Free Recombinant CA19-9 Antibody (clone CA19

IHC testing of FFPE human gastric carcinoma with recombinant CA19-9 antibody (clone CA19.9/1390R). HIER: steam sections in pH6 citrate buffer for 10-20 min.~
SDS-PAGE Analysis of Purified, BSA-Free Recombinant CA19-9 Antibody (clone CA19

No additional charges, what you see is what you pay! *

CodeSizePrice
NSJ-V7255SAF-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Application Details:
Immunohistochemistry (FFPE): 5-10ug/ml for 30 min at RT
Application Note:
Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Description:
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
Format:
Purified
Formulation:
1 mg/ml in 1X PBS; BSA free, sodium azide free
Immunogen:
Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
Limitation:
This recombinant CA19-9 antibody is available for research use only.
Localization:
Cytoplasmic
Purity:
Protein A affinity

Documents